Medicinal products – Open-house rebate agreements 2026-24 for Aflibercept

Summary

The tender concerns medicinal products under an open-house scheme for Aflibercept (ATC: S01LA05; strength: 40 mg/ml). The contracting authority aims to conclude rebate agreements with all suitable pharmaceutical companies under uniform conditions, without individual negotiations and without exclusivity. The contract term is up to 12 months from 01/08/2026 and ends no later than 31/07/2027; it may be extended by 12 months. Further details are in the participation and contract documents.